Skip to content
Search

Latest Stories

Over one million: India joins the US, Brazil in grim Covid-19 club

INDIA on Friday (17) became the third country in the world to record more than one million cases of the new coronavirus, behind only the US and Brazil, as infections spread further into the countryside and smaller towns.

Given India's population of around 1.3 billion, experts say, one million is relatively low - but the number will rise significantly in the coming months as testing increases, further straining a healthcare system already pushed to the brink.


The pandemic has surged in the country in recent weeks as it spread beyond the biggest cities, pushing India past Russia as the third-most-infected country last week.

Authorities imposed fresh lockdowns and designated new containment zones in several states this week, including the largely rural Bihar state in the east and the southern tech hub Bengaluru, where cases have spiked.

But officials have the struggled to enforce the lockdowns and keep people indoors.

India recorded 34,956 new infections on Friday, taking the total to 1,003,832, with 25,602 deaths from Covid-19, federal health ministry data showed. That compares to 3.6 million cases in the US and two million in Brazil - countries with less than a third of India's population.

Epidemiologists say India is still likely months from hitting its peak.

"In the coming months, we are bound to see more and more cases, and that is the natural progression of any pandemic," said Giridhar Babu, epidemiologist at the nonprofit Public Health Foundation of India.

"As we move forward, the goal has to be lower mortality," he said. "A critical challenge states will face is how to rationally allocate hospital beds."

The last four months of the pandemic sweeping India have exposed severe gaps in the country's healthcare system, which is one of the most poorly funded and has for years lacked enough doctors or hospital beds.

The Indian government has defended a strict lockdown it imposed in March to contain the virus spread, saying it helped keep death rates low and allowed time to beef up the healthcare infrastructure. But public health experts say shortages remain and could hit hard in the coming months.

"As a public health measure, I don’t think the lockdown had much impact. It just delayed the virus spread," said Dr. Kapil Yadav, assistant professor of community medicine at New Delhi's premier All India Institute of Medical Sciences.

The million cases so far recorded likely left out many asymptomatic ones, he said. "It's a gross underestimate."

Rahul Gandhi, leader of the opposition Congress party, urged prime minister Narendra Modi to take concrete steps to contain the pandemic, tweeting that the number of infections will double to two million by August 10 at this pace.

Millions of migrant workers, left stranded in the cities by the lockdown in March, took long journeys home on foot, some dying on the way while others left without work or wages.

Several states including Bihar, to which many of the migrants returned, have witnessed a surge in cases in recent weeks as the lockdown has been eased to salvage a sagging economy.

Babu predicts India will not see a sharp peak and decline.

"The surges are shifting from one place to another, so we cannot say there will be one peak for the whole country. In India, it’s going to be a sustained plateau for some time and then it will go down."

More For You

Coca-Cola Issues Recall for 900 Cases Due to Plastic Contamination

The recall is classified as a Class II event by the FDA

iStock

Coca-Cola recalls nearly 900 cases due to plastic contamination

Reyes Coca-Cola Bottling, LLC, based in Milwaukee, Wisconsin, has initiated a recall of nearly 900 cases of Coca-Cola Original Taste due to potential contamination with plastic. The recall affects 864 12-pack cases of Coca-Cola, which were distributed to retailers in Illinois and Wisconsin. The recall was announced on 6th March 2025, and is currently still in progress, according to the Food and Drug Administration (FDA).

The recall is classified as a Class II event by the FDA, which means that while the risk of severe health consequences is considered low, consumers may still experience temporary or reversible adverse effects. Plastic contamination in beverages poses a number of risks, including the potential for choking, oral injuries, or gastrointestinal discomfort if consumed.

Keep ReadingShow less
The importance of good quality sleep

Simple changes can make you feel refreshed and energised

The importance of good quality sleep

QUALITY sleep is essential for mental and physical well-being, as well as overall quality of life.

However, in today’s fast-paced world, many struggle with insomnia and restless nights. World Sleep Day on March 14 celebrated the benefits of a healthy night’s rest, while raising much-needed awareness about an area of life that is perhaps not given enough attention.

Keep ReadingShow less
Jane Fonda’s Fitness Secrets: How She Stays Strong in Her 80s

Jane Fonda is widely recognised as one of the pioneers of the home workout movement

Getty Images

How Jane Fonda maintains her incredible fitness in her 80s


At 87 years old, Jane Fonda continues to impress with her incredible fitness and energy. As an actress, producer, and fitness icon, Fonda has inspired millions with her dedication to staying active, and her influence on the world of home workouts is undeniable. Despite her age, Fonda remains committed to her fitness routine, demonstrating that exercise is essential for maintaining independence and a high quality of life as you grow older.

Keep ReadingShow less
Eli Lilly

This price point is significantly lower than in the USA

Getty Images

Eli Lilly introduces Mounjaro in India, gaining an edge over Novo Nordisk in the weight-loss drug market


Eli Lilly has launched its highly anticipated diabetes and weight-loss medication, Mounjaro, in India, marking the company's entry into the country’s rapidly growing market for treatments tackling obesity and diabetes. The U.S.-based pharmaceutical giant has outpaced Danish competitor Novo Nordisk, becoming the first to offer such a drug in India.

Keep ReadingShow less